Stabilization of Phenobarbital Sodium for Injection in Specialized Environments

Publication ID: 24-11857683_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Stabilization of Phenobarbital Sodium for Injection in Specialized Environments,” Published Technical Disclosure No. 24-11857683_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857683_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,683.

Summary of the Inventive Concept

The inventive concept adapts the stabilization of phenobarbital sodium for injection to meet the unique demands of high-altitude, disaster relief, extreme weather, high-security, and remote or resource-limited environments.

Background and Problem Solved

The original patent addressed the stabilization of phenobarbital sodium for injection, but it did not consider the specific challenges posed by specialized environments. The new inventive concept addresses these limitations by providing tailored solutions for these niche markets.

Detailed Description of the Inventive Concept

The inventive concept encompasses four specialized variations: 1) a system for stabilizing phenobarbital sodium in high-altitude environments, featuring a specially designed container to maintain pressure; 2) a method for reconstituting the lyophilized composition in disaster relief scenarios, with a focus on rapid administration; 3) a lyophilized composition adapted for extreme cold weather conditions, stored in a thermally insulated container; and 4) a system for stabilizing phenobarbital sodium in high-security facilities, utilizing a tamper-evident container. Additionally, the inventive concept includes a method for treating neonatal seizures in remote or resource-limited environments, incorporating a portable vital signs monitor.

Novelty and Inventive Step

The new inventive concept introduces novel features that adapt the stabilization of phenobarbital sodium for injection to specific, high-demand environments. The inventive step lies in the combination of the original patent's stabilization technology with specialized containers, reconstitution methods, and monitoring systems tailored to each niche market.

Alternative Embodiments and Variations

Alternative embodiments may include using different container materials or designs, modifying the reconstitution process, or incorporating additional monitoring systems. Variations could also involve adapting the inventive concept to other pharmaceutical compounds or medical conditions.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the pharmaceutical industry, particularly in the areas of emergency medicine, disaster relief, and high-security facilities. The target markets include hospitals, emergency responders, and specialized medical facilities operating in challenging environments.

CPC Classifications

SectionClassGroup
A A61 A61K9/19
A A61 A61K9/08
A A61 A61K31/515
A A61 A61K47/10
A A61 A61P25/08

Field of Art

Pharmaceutical formulation and drug delivery, specifically focused on lyophilized injectable pharmaceutical compositions, with expertise in stabilization techniques, pharmaceutical chemistry, and medical device design

Person of Ordinary Skill (PHOSITA) Profile

A pharmaceutical scientist or chemical engineer with advanced degree, experience in drug formulation, knowledge of stability testing, understanding of container design, and familiarity with specialized medical environments

Obviousness Rationale

A PHOSITA would recognize that the specialized environmental adaptations of the phenobarbital sodium lyophilized composition represent predictable variations of the source patent's core stabilization technology. The fundamental chemical composition remains substantially unchanged, with modifications primarily addressing container design, reconstitution methods, and deployment contexts. These adaptations represent standard engineering problem-solving approaches within pharmaceutical product development.

Obvious Combinations & Variations

Source Patent Element
Lyophilized phenobarbital sodium composition with controlled ethanol content for stability
PTD Variation
High-altitude container design maintaining pressure stability
Obviousness Reasoning
Container pressure management is a known engineering solution for maintaining pharmaceutical integrity in variable environmental conditions, representing a predictable design modification
Source Patent Element
Lyophilized pharmaceutical composition with specific impurity control
PTD Variation
Rapid reconstitution method for disaster relief scenarios
Obviousness Reasoning
Modifying reconstitution protocols represents a standard pharmaceutical engineering adaptation addressing specific use-case requirements, utilizing known diluent options
Source Patent Element
Phenobarbital sodium composition with ethanol-based stabilization
PTD Variation
Thermally insulated container for extreme cold weather deployment
Obviousness Reasoning
Thermal protection for pharmaceutical products is a well-established technique for maintaining compositional integrity, representing a finite and predictable solution to environmental challenges
Source Patent Element
Lyophilized pharmaceutical composition with controlled chemical parameters
PTD Variation
Tamper-evident container for high-security facility deployment
Obviousness Reasoning
Security-focused container modifications represent standard pharmaceutical packaging engineering approaches addressing institutional requirements
Source Patent Element
Method for treating neonatal seizures using lyophilized composition
PTD Variation
Portable vital signs monitoring integration for remote environments
Obviousness Reasoning
Combining pharmaceutical delivery with patient monitoring represents a predictable medical technology integration, solving known challenges in resource-limited settings
35 U.S.C. § 103 Summary: Based on US Patent 11857683's teachings, the present publication demonstrates that the specialized environmental adaptations of lyophilized phenobarbital sodium compositions would be obvious to a person having ordinary skill in pharmaceutical formulation, as the core chemical composition remains substantially unchanged while addressing predictable deployment challenges through standard engineering modifications.

Original Patent Information

Patent NumberUS 11,857,683
TitleStabilization of phenobarbital sodium for injection
Assignee(s)SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED